NCT05018273CompletedPhase 1
A Phase 1b, Open-Label, Dose-Escalation Trial of the Safety of and Antigen-Specific Immune Responses Elicited by VB.10 NEO in Combination With Atezolizumab in Subjects with Locally Advanced and Metastatic Tumors
Source: EU CTIS (euclinicaltrials.eu) · Last updated 23 Jul 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 25 Jan 2024
- Start date
- 18 Jan 2022
- Lead sponsor
- Nykode Therapeutics ASA
- Diseases
- Triple-negative breast cancer, Head and neck cancer, Kidney cancer, Bladder cancer, Cervical cancer, Lung cancer, Metastatic breast cancer, Gastric and esophageal cancer
- NCT number
- NCT05018273
- EU CT number
- 2023-509996-18-00
- EudraCT number
- 2020-006025-56
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 40
- 7 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charite Research Organisation GmbH Coordinator of this site? Confirm its status | Berlin | Germany | Completed |
| Universitaetsklinikum Heidelberg AöR Coordinator of this site? Confirm its status | Heidelberg | Germany | Completed |
| Hospital de la Santa Creu i Sant Pau Coordinator of this site? Confirm its status | Barcelona | Spain | Completed |
| Hospital Universitari Vall d'Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Completed |
| Hospital General Universitario Gregorio Marañón Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
| Hospital Universitario La Paz Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
| Hospital Universitario Virgen de la Victoria Coordinator of this site? Confirm its status | Málaga | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.